These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?]. Bourgault-Villada I Ann Dermatol Venereol; 1998 Dec; 125(12):879-80. PubMed ID: 9922858 [No Abstract] [Full Text] [Related]
3. Common and alternate oral antibiotic therapies for acne vulgaris: a review. Amin K; Riddle CC; Aires DJ; Schweiger ES J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358 [TBL] [Abstract][Full Text] [Related]
4. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337 [TBL] [Abstract][Full Text] [Related]
7. Optimizing use of oral antibiotics in acne vulgaris. Del Rosso JQ; Kim G Dermatol Clin; 2009 Jan; 27(1):33-42. PubMed ID: 18984366 [TBL] [Abstract][Full Text] [Related]
8. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. Patel M; Bowe WP; Heughebaert C; Shalita AR J Drugs Dermatol; 2010 Jun; 9(6):655-64. PubMed ID: 20645527 [TBL] [Abstract][Full Text] [Related]
9. The use of oral antibiotics in treating acne vulgaris: a new approach. Farrah G; Tan E Dermatol Ther; 2016 Sep; 29(5):377-384. PubMed ID: 27306750 [TBL] [Abstract][Full Text] [Related]
10. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne]. Noyon V; Legallou F; Richet H; Dreno B Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance in the topical treatment of acne vulgaris. Leyden JJ Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128 [TBL] [Abstract][Full Text] [Related]
13. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Sagransky M; Yentzer BA; Feldman SR Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357 [TBL] [Abstract][Full Text] [Related]
14. Acne and Propionibacterium acnes. Bojar RA; Holland KT Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721 [TBL] [Abstract][Full Text] [Related]
15. General considerations by a clinical bacteriologist regarding antibiotic therapy in acne. Holm SE; Burman LG Acta Derm Venereol Suppl (Stockh); 1980; Suppl 89():83-5. PubMed ID: 6451131 [No Abstract] [Full Text] [Related]
16. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy]. Abeck D MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325 [No Abstract] [Full Text] [Related]
17. The evolving role of Propionibacterium acnes in acne. Leyden JJ Semin Cutan Med Surg; 2001 Sep; 20(3):139-43. PubMed ID: 11594668 [TBL] [Abstract][Full Text] [Related]
19. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? Kinney MA; Yentzer BA; Fleischer AB; Feldman SR J Drugs Dermatol; 2010 May; 9(5):519-24. PubMed ID: 20480795 [TBL] [Abstract][Full Text] [Related]